PET-CT and DOTATATE PET cost in pancreatic cancer — what you are actually paying for

Anyone typing “PET CT cost pancreatic cancer” into a search box wants one number back. There is no single number, and the more useful answer sits one step earlier: a PET-CT is not part of the routine pancreatic work-up, so before you price it, find out whether you need it. The scan is added when a specific question needs answering. If nobody can tell you what that question is, the money is better kept.

The second thing to know is who raises the bill. CION does not run a PET scanner. PET-CT and DOTATATE PET are coordinated with partner imaging and nuclear medicine centres, performed there, and may be billed there. We decide with you whether the scan is worth doing, tell the centre exactly what it has to answer, and read the report back into your plan — but the scan itself is billed by that centre, not by us. Saying so plainly matters, because it means two organisations and two billing desks rather than one.

Three things move a quotation more than anything else. Which scan is being booked, because a routine PET-CT and a DOTATATE PET use different tracers that are made and delivered differently. How much of the body is covered. And whether a full diagnostic contrast CT is done in the same sitting, or only a low-dose CT to localise and correct the PET images. Those are genuine differences in what is being delivered, and they are why two quotations for what sounds like the same scan are often not comparable at all.

If you have been offered the scan but not told why, start with when a PET-CT is actually used in pancreatic cancer. If your diagnosis is a neuroendocrine tumour rather than an adenocarcinoma, the relevant scan is a different one, and DOTATATE PET-CT for pancreatic neuroendocrine tumours explains what it shows and why it is booked around tracer supply.

• Which scan has actually been requested. A routine PET-CT and a DOTATATE PET are different studies with different tracers, different availability and different prices. Get the request in writing before you compare centres.
• Whether a diagnostic contrast CT is included. If a full pancreatic-protocol CT is bundled into the sitting, the quotation should be higher — and you should not then be paying for the same CT twice elsewhere.
• How much of the body is covered. A skull-base-to-thigh study and a whole-body study are not the same slot, the same dose or the same figure.
• Whether the tracer is produced on site or delivered. Centres that rely on a delivered dose run these scans on fixed days in batches. That shapes the date you are offered as much as the price, and both matter when treatment is waiting.
• What happens if you cannot attend. Ask the cancellation rule plainly. A dose ordered for your slot decays whether or not you arrive, so it is usually charged.
• Whether your blood sugar needs settling first. High sugars on the day can degrade the images enough to force a repeat study, which is the most avoidable extra cost on this page.
• How the report reaches your oncologist. A study that sits at the imaging centre while you chase a disc has cost you time as well as money. Agree the route before you leave.
• Whether the result would change the plan. This is the question that decides whether the money is worth spending at all. If the honest answer is no, we will tell you so, and the alternative routes are set out in pancreatic cancer treatment in Hyderabad.

Cover for a scan behaves differently from cover for an operation, and that difference catches families out. Scheme and policy packages are usually built around a treatment episode rather than around a single test, so whether a PET-CT is paid for often depends on what it is attached to and when it is done, not on the scan alone. The question to ask is never simply “is PET-CT covered” but “is it covered for me, at this centre, at this point in my treatment”.

Aarogyasri in Telangana and NTR Vaidya Seva in Andhra Pradesh both cover eligible cancer care at empanelled hospitals under defined packages, with pre-authorisation raised before the test rather than claimed afterwards. Because the scan is performed at a partner imaging or nuclear medicine centre, entitlement has to be valid at that centre, not at ours. PMJAY applies for eligible families, and the schemes for serving and retired government staff work along similar lines. Establish empanelment before a date is fixed, not on the morning of the appointment.

Private insurance is where most of the unpleasant surprises live. Outpatient diagnostics are commonly excluded or sub-limited unless they form part of an inpatient or defined day-care episode, so a scan done as a standalone appointment can fall outside a policy that would have covered the identical scan during an admission. Ask your insurer three things in writing: whether the proposed centre is in network, whether this scan is payable as an outpatient investigation, and what pre-authorisation it needs. Waiting periods on a recently bought policy apply here as they do everywhere else.

What CION does about all of this is straightforward. The first consultation is free and lasts 45 minutes. Bring your scan discs rather than only the reports. A medical oncologist reviews the imaging, says plainly whether a PET-CT or DOTATATE PET would change the decision in front of you, and takes the case to a tumour board where medical, surgical and radiation oncologists look at it together. Only then does a cost conversation make sense. You get a written estimate showing what CION bills and what the partner centre bills, with the scheme and insurance position checked with you rather than left to be discovered at a reception desk. For the wider picture of diagnosis, staging and treatment, the complete pancreatic cancer guide is the place to start.

Medical disclaimer: This page explains how the cost of PET-CT and DOTATATE PET imaging in pancreatic disease is structured and who bills which part of the pathway, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma and neuroendocrine tumours. It is general information and not a quotation, an offer or a substitute for individual medical and financial advice; no prices are quoted here because the figure depends on which study is requested, which centre performs it and what it includes, and must be set out for you in a written estimate. Consultation and scan review, the tumour-board decision on whether functional imaging is indicated, pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods, chemotherapy, radiation, chemoradiation and SBRT, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain and psycho-oncology care and survivorship follow-up are delivered and billed by CION across 35+ centres. PET-CT, DOTATATE PET and PRRT, endoscopic ultrasound and biopsy, ERCP and biliary or duodenal stenting, coeliac plexus block, staging laparoscopy and all pancreatic surgery are coordinated with partner imaging, nuclear medicine, gastroenterology, endoscopy and specialist hepatobiliary centres and may be billed there. Scheme and insurance eligibility is determined by the scheme or insurer, not by CION.